Pharmaceutical Engineering Articles
Articles published in Pharmaceutical Engineering, ISPE’s bi-monthly member magazine that relate to the
subject matter of the Biotech COP.
- Follow-on Biologics:
Will the New Biologics Price Competition and Innovation Act Live Up to the Waxman-Hatch 1984
Expectations?
March/April 2013, 33(2)
by Michael R. Goodman
- Facility of the Future:
Next Generation Manufacturing Forum Part I: “Why We Cannot Stay Here” – The Challenges, Risks, and Business
Drivers for Changing the Paradigm
January/February 2013, 33(1)
by Mark F. Witcher, PhD, Ruben Carbonell, PhD, Jeff Odum, CPIP, Peter Bigelow, Patricia Lewis, and Michael
Zivitz
- Biopharmaceutical Manufacturing in the
Twenty-First Century – the Next Generation Manufacturing Facility
March/April 2012, 32(2)
by Mark F. Witcher, PhD and Jeff Odum CPIP
- Design and Optimization of a Large Scale Biopharmaceutical
Facility Using Process Simulation and Scheduling Tools (
5 MB) 
March/April 2010, 30(2)
by Abdelaziz Toumi, Carmen Jungo, Mr. Victor Papavasileiou, Mr. Demetri Petrides, Christian Jürgens, Bernd
Maier
- Biopharmaceutical Process Characterization: Defining the
Design Space (
273 KB) 
March/April 2008, 28(2)
by Anthony Newcombe, Keith Watson, Claire Newcombe
- ISPE Baseline® Pharmaceutical Engineering Guide for New and
Renovated Facilities Volume 6: Biopharmaceutical Manufacturing Facilities – Executive Summary (
211 KB) 
September/October 2007, 27(5)
- Primer of Design and Construction Delivery Methods for Today’s
Modern Pharmaceutical and Biotech Facilities (
228 KB) 
May/June 2006, 26(3)
by Brian Sirbovan, Dave DiProspero, Brian Larson
- Capital Costs for Biopharmaceutical Process Retrofit
Projects (
363 KB) 
May/June 2006), 26(3)
by Stephen R. Higham
- Biotech CIP Cycle Development: Case Study Examples Utilizing
QRM (
197 KB) 
September/October 2006, 26(5)
by Matt Wiencek
- The Role of Process Simulation in a Renovated Biologics
Facility – A Case Study (
486 KB) 
September/October 2006, 26(5)
by Daniel Lavin, Himabindu Gopisetti, Peter N. Notwick
- Process Modeling Proposition in Biopharmaceutical
Manufacturing (
225 KB) 
November/December 2005, 25(6)
by Sei Murakami, Peter Watler, Takashi Ishihara, Shuichi Yamamoto
- Project Scope Determination and Cost Control Using Technology
Assessment Diagrams – A Biopharmaceutical (
331 KB) 
November/December 2005, 25(6)
by Mary Ellen Craft
- Biotech: A Wealth of Choices (
92 KB) 
March/April 2005), 25(2)
by Thom Hallock
Other Articles
- A Statistical Approach to Expanding Production Capacity
BioProcess International, March 2013
by Annette Kaya, Andrea Uebele, Anke Seeger, Hans ter Maat, David Estapé
- Developing an Integrated Continuous Bioprocessing Platform
BioProcess International, December 2012
by Maribel Rios
- Virus Safety of Biopharmaceuticals
Contract Pharma, November 2011
by Hazel Aranha, Ph.D.
- Challenging the Cleanroom Paradigm for Biopharmaceutical Manufacturing of Bulk Drug
Substances
BioPharm International, August 2011
by Simon Chalk, Scott Probst, Paul Gil, Tim Palberg, Matt Kennedy, Joe Rogalewicz, Jeff Johnson, Ken
Green

Indicates content available to ISPE members only.